In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Video Forum: Dave Warner, KPH Healthcare Services
Kinney Drugs parent finds strength in diversification.
Video Forum: Ellen Kelsay, Business Group on Health
Examining health care through the lens of employers.
Latest
CRN opposes California protein powder bill
This legislation introduces new testing, disclosure, and labeling rules for protein powder and concentrated proteins sold in California.
L’Oréal gains momentum in U.S. as beauty market improves
Momentum in the U.S. grew driven by premium haircare, fragrance, and dermatologist-backed skincare.
Walmart and The Walmart Foundation announce $1 million total investment in winter storm relief
This combined $1 million investment has provided critical support to more than 30 city governments and local organizations.
FMI releases statement on January CPI food price numbers
“The food industry remains committed to keeping prices as low as possible for households across the country.”